Podcast: Endpoints Shorts: Dr. Nadia Sethi on MedicNova's Ibudilast Clinical Trial

The Endpoints Podcast features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. Each episode cuts to the chase with short, digestible conversations about the latest research at ALS TDI and the most closely watched ALS clinical trials as well as stories from people living with ALS with their thoughts on research, healthcare and their journey with ALS.

Select episodes of the Endpoints Podcast are now available on Spotify and iTunes. Please email endpoints@als.net with feedback and suggestions for future episodes.

The Endpoints theme music was created by Robert Labadie.

5/26/2023

Endpoints Shorts: Dr. Nadia Sethi on MedicNova's Ibudilast Clinical Trial

Welcome to the latest episode of Endpoints Shorts, presented by the ALS Therapy Development Institute.

In these bite-size podcasts, we’ll be tackling important scientific concepts for people interested in ALS research, current clinical trials, and news from around the ALS space – all in 15 minutes or less.

Our guide throughout this series will be Dr. Nadia Sethi, ALS TDI’s Director of Community Outreach and Engagement. Today, Nadia joins us to talk about MedicNova’s phase 2/3 trial for Ibudilast.

Welcome to the latest episode of Endpoints Shorts, presented by the ALS Therapy Development Institute.

Our guide throughout this series will be Dr. Nadia Sethi, ALS TDI’s Director of Community Outreach and Engagement. Today, Nadia joins us to talk about MedicNova’s phase 2/3 trial for Ibudilast.

Thank you to our Sponsors